Close

JMP Securities Downgrades Ovid Therapeutics Inc (OVID) to Market Perform

December 2, 2020 3:34 AM EST Send to a Friend
JMP Securities analyst Jason N. Butler downgraded Ovid Therapeutics Inc (NASDAQ ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE

Member Login